Abstract 2060P
Background
The aim of the study is to identify the prevalence and predictors of mental adjustment to cancer in patients who were going to resect lung for non-small cell lung cancer in Korea.
Methods
A total of 697 patients were recruited from September 2021 to October 2022 and completed a survey questionnaire of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) which higher mean score denote worse mental adjustment, except for positive attitude (PA) domain. Multivariable logistic regression was analyzed to determine potential predictors of poor adjustment to cancer for each domain of K-mini-MAC, which was defined by the mean score of 2.5 or higher, while PA domain was defined by mean score of 2.5 or lower.
Results
The mean age of study population was 63.2 ± 0.4 years old and 50.4% was male. The proportion of poor mental adjustment was 6.0% (Helpless/Hopeless [HH] domain), 29.6% (Anxious Preoccupation [AP] domain), 19.1% (PA domain), and 30.1% (Cognitive Avoidance [CA] domain). The mean score of each domain was 1.60 ± 0.02 (HH), 2.17 ± 0.02 (AP), 2.83 ± 0.02 (PA), and 2.62 ± 0.02 (CA). Younger age (<65 years old, aOR 1.78, 95% CI 1.15-2.76) and having comorbidity (aOR 1.64, 95% CI 1.09-2.45) were associated with poor mental adjustment in AP domain, while current alcohol drinking was associated with better mental adjustment in AP domain (aOR 0.56, 95% CI 0.32-0.96, vs. non-alcohol drinker). Poor mental adjustment in PA domain was predicted based on Lower education level (≤ middle school, aOR 1.97, 95% CI 1.12-3.46; high school, aOR 2.31, 95% CI 1.23-4.36, vs. ≥ university). There was no significant predictor for mental adjustment in HH and CA domain.
Conclusions
Younger, non-alcohol drinker, having comorbidity and lower educational level was associated with a poor adjustment to cancer. Interventions to help with adjustment to cancer should be focused particularly on these group.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
This research was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (Grant Number: MSIT; 2019R1A2C2009751).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06
2095P - Cancer rehabilitation program for cancer-related fatigue
Presenter: Aizhan Bekisheva
Session: Poster session 06